Figure 2.

Serum anti-Müllerian hormone (AMH) distribution among the patients in the present study (A) In patients who did not conceive (74.5% of the patients’ levels were below the detection limit), only the levels of samples in which AMH was measurable are plotted. (B) In patients who achieved a live birth (70.7% of the patients’ levels were below the detection limit), only the levels of samples in which AMH was measurable are plotted.